Hexagon Nutrition Limited (HEXAGON)
₹59.91 -0.13% இன்றைய முடிவு விலை
சுருக்கம்
Hexagon Nutrition Limited closed at ₹59.91 on 12 Nov 2026, with an RSI(14) of 44.4. On the daily chart it is in a weak downtrend, with a technical score of 14/100 (strong bearish). In the quarter ended June 2026, revenue grew 43.2% and net profit grew 25.0% from a year earlier. The board meets on 14 Nov 2026 to consider the Q2 FY27 results. Data as of 12 Nov 2026.
விலை
- விலை
- ₹59.91
- நாள் மாற்றம்
- -0.13%
- சந்தை மதிப்பு
- ₹736 கோடி
- 52-வார வரம்பு
- ₹48.10 – ₹78.25
- 52-வார உச்சத்திலிருந்து
- -23.44%
- 52-வார தாழ்விலிருந்து
- +24.55%
பங்கு உரிமைசெப். 2026
- புரமோட்டர்கள்
- 64.36%
- FII-கள்
- 0.29%
- DIIs
- 4.12%
செப்டம்பர் 2026 உடன் முடிவடைந்த காலாண்டுக்கான பங்குதாரர் விவரம்; சதவீதப் புள்ளிகளில் மாற்றங்கள்.
நிகழ்வுகள்
- அடுத்த முடிவுகள்
- 14 நவ. 2026 (Q2 FY27)
- சமீபத்திய முடிவுகள்
- Q1 FY27, தாக்கல் செய்யப்பட்டது 13 ஆக. 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 30 செப். 2026
நிதிநிலை12 நவ. 2026
- YoY காலாண்டு விற்பனை வளர்ச்சி
- 43.2%
- YoY காலாண்டு லாப வளர்ச்சி
- 25.0%
சமீபத்திய காலாண்டு ஜூன் 2026 · ஒருங்கிணைந்த
பங்குச் சந்தை செயல்பாடு12 நவ. 2026
- டெலிவரி
- 58.07% எதிர் சராசரி 55.68%
- வால்யூம் அதன் சராசரியுடன் ஒப்பீடு
- 0.4×
- இன்சைடர் வர்த்தகம்
- 12 disclosed in 90 days, net buying ₹87.1 lakh on the market
டெக்னிக்கல்ஸ்12 நவ. 2026
- போக்கு
- பலவீனமான இறக்கப் போக்கு
- தொழில்நுட்ப மதிப்பெண்
- 14/100 · வலுவான இறக்கத்துக்கு சாதகமான (strong bearish)
- MACD
- ஏற்றத்துக்கு சாதகமான (bullish)
- RSI (14)
- 44.40
- ADX (14)
- 23.34
- SuperTrend
- இறக்கத்துக்கு சாதகமான (bearish)
- 20-நாள் SMA-உடன் ஒப்பீடு
- -3.08%
- 50-நாள் SMA-உடன் ஒப்பீடு
- -7.76%
- அருகிலுள்ள சப்போர்ட்
- ₹52.20
- அருகிலுள்ள ரெசிஸ்டன்ஸ்
- ₹62.16
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
📅 அடுத்த நிதி முடிவுகள்: 14 நவ. 2026 (இயக்குநர் குழுக் கூட்டம்)Hexagon Nutrition Limited-இன் இயக்குநர் குழுக் கூட்டம் 14 நவ. 2026 அன்று நடைபெறுகிறது; அதில் அதன் Q2 FY27 முடிவுகள் பரிசீலிக்கப்படும் (ஜூலை-செப்டம்பர் 2026).
In its latest reported quarter, Q1 FY27, Hexagon Nutrition's revenue was ₹104 Cr (+43.2% year on year, -9.3% on the previous quarter), and net profit ₹8.1 Cr (+25.0% year on year); the operating margin was 11.3%.
| Q1 FY27 (₹ கோடி) | மதிப்பு | YoY Q1 FY26-உடன் | QoQ |
|---|---|---|---|
| வருவாய் | ₹104 | +43.2% | -9.3% |
| செயல்பாட்டு லாபம் | ₹11.7 | +16.8% | -22.1% |
| நிகர லாபம் | ₹8.1 | +25.0% | -25.9% |
| EPS (₹) | 0.67 | +15.5% | -32.3% |
| செயல்பாட்டு லாப வரம்பு | 11.3% | — | — |
HEXAGON டெலிவரி சதவீதம்
க்கான NSE EOD தரவு
On Thu, 12 Nov 2026, 58.07% of the HEXAGON shares traded on NSE were taken to delivery, against the stock's own 20-session average of 55.68%. That is close to its usual level. Volume was 0.4 times its average, well below normal.
கடந்த 5 அமர்வுகளில் டெலிவரி: 59.4% · 63.4% · 54.2% · 74.3% · 58.1%
பங்குச் சந்தை வெளியிட்டவற்றின் விளக்கம், பரிந்துரை அல்ல. "accumulation" அல்லது "லாங் பில்டப்" போன்ற பெயர்கள் எண்களில் உள்ள ஒரு வடிவத்தை குறிக்கின்றன. டெலிவரி எவ்வாறு பகுப்பாய்வு செய்யப்படுகிறது
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Hexagon Nutrition Limited's shareholders have formally approved the appointment of Mr. Arun Purushottam Kelkar as Executive Director and Chairman of the company for a 5-year term effective October 28, 2026. The approval took place at the company's 1st Extra-Ordinary General Meeting. Mr. Kelkar brings over 40 years of industry experience and has been with the company since its incorporation. He is the father of Managing Director Vikram Arun Kelkar and Dr. Nikhil Arun Kelkar.
- Shareholders approved the appointment of Mr. Arun Purushottam Kelkar at the 1st EGM held on October 28, 2026.
- Appointed as Executive Director and Chairman for a term of 5 years effective October 28, 2026.
- Mr. Kelkar brings over 4 decades of experience across diverse industries including food and nutrition.
- Disclosed family relationships: father of Managing Director Vikram Arun Kelkar and Dr. Nikhil Arun Kelkar.
Hexagon Nutrition Limited announced that all 4 special resolutions were approved at its Extra Ordinary General Meeting (EGM) held on October 28, 2026. Shareholders approved the appointment of Mr. Arun Purushottam Kelkar as Executive Director and Chairman, along with his remuneration for the period from April 1, 2026 to September 28, 2026 and for a 3-year term. In addition, remuneration payable to Managing Director Vikram Kelkar effective April 1, 2026 was passed. Total votes polled across resolutions were 8,29,55,809 shares (67.4887% of total shares), with over 99.99% voting in favour.
- Resolution 1 for appointment of Mr. Arun Purushottam Kelkar as Executive Director and Chairman passed unanimously with 100% votes in favour.
- Resolutions 2, 3, and 4 on promoter/executive remuneration passed with 8,29,55,476 votes (99.9996%) in favour and 333 votes against.
- Total voter turnout stood at 67.4887% of outstanding shares (8,29,55,809 votes polled out of 12,29,18,109 shares).
- Promoter and Promoter Group accounted for 7,91,06,800 votes (100% turnout and 100% in favour).
Hexagon Nutrition Limited conducted an Extraordinary General Meeting (EGM) on October 28, 2026, pursuant to a requisition notice dated September 24, 2026. Shareholders considered four special resolutions regarding the appointment and remuneration of Mr. Arun Purushottam Kelkar as Executive Director and Chairman, as well as the remuneration of Managing Director Mr. Vikram Kelkar. A total of 50 members attended (49 via video conference and 1 physically), with final voting results to be submitted separately. The filing details procedural proceedings and regulatory compliance without disclosing specific remuneration amounts.
- EGM conducted on October 28, 2026, from 11:30 a.m. to 12:02 p.m. IST
- 49 members attended via video conferencing and 1 attended physically
- 4 special resolutions tabled regarding Executive Director and MD appointments and remuneration
- Voting results and Scrutinizer's Report to be submitted separately under Regulation 44
Hexagon Nutrition Limited has dispatched physical letters to shareholders whose email addresses are not registered, providing weblinks to access the Notice of its upcoming Extra-Ordinary General Meeting (EGM). The EGM is scheduled to be held on Wednesday, October 28, 2026, at 11:30 AM IST via Video Conference and Other Audio-Visual Means. The filing serves as a procedural compliance intimation under Regulation 30 of SEBI LODR Regulations without disclosing the specific resolutions to be voted on. In its recent quarterly performance for June 2026, the company reported revenue of Rs 104.31 crore and a net profit of Rs 8.07 crore.
- EGM scheduled for Wednesday, October 28, 2026, at 11:30 AM IST via VC/OAVM
- Letters dispatched to shareholders without registered email addresses with details to access notice via weblink
- Notice made available on company website under Regulation 46 disclosures as well as BSE and NSE
- Company reported June 2026 quarterly revenue of Rs 104.306 cr and net profit of Rs 8.073 cr
Hexagon Nutrition has issued a notice convening an Extraordinary General Meeting (EGM) on October 28, 2026, requisitioned by shareholders holding 45.81% equity. The meeting seeks shareholder approval to appoint 76-year-old Mr. Arun Purushottam Kelkar as Executive Director and Chairman for 5 years, along with annual remuneration of up to ₹1.82 crore. Additionally, approval is sought for annual remuneration of up to ₹2.42 crore for Managing Director Mr. Vikram Kelkar effective April 1, 2026. Remote e-voting is scheduled between October 25 and October 27, 2026.
- EGM requisitioned by members holding 56,296,871 shares (45.81% of paid-up equity capital)
- Proposed appointment of Mr. Arun Purushottam Kelkar (age 76) as Chairman & Executive Director for a 5-year tenure
- Proposed remuneration of up to ₹1,82,00,000 per annum for Mr. Arun Kelkar
- Proposed remuneration of up to ₹2,42,00,000 per annum for Managing Director Mr. Vikram Kelkar
- EGM date set for October 28, 2026, with cut-off date on October 21, 2026
Hexagon Nutrition's Board has taken note of requisition letters received on September 24, 2026, from promoter shareholders to convene an Extraordinary General Meeting (EGM). Shareholders holding 38.41% requested an EGM to appoint Mr. Arun Purushottam Kelkar as Executive Director and Chairman and approve his remuneration. Another requisition from shareholders holding 24.67% requested approval for remuneration payable to Managing Director Mr. Vikram Kelkar effective April 1, 2026. The board considered convening an EGM to seek shareholder approval for these matters.
- Requisition received from shareholders holding 38.41% equity to appoint Arun Purushottam Kelkar as Executive Director and Chairman
- Approval sought for remuneration of Managing Director Vikram Kelkar with effect from April 1, 2026, by 24.67% shareholding group
- Board considered proposal to convene an Extraordinary General Meeting (EGM) to seek shareholder approvals
- Trading window closed from October 1, 2026, until 48 hours after Q2 FY27 financial results declaration
Hexagon Nutrition Limited and Particles for Humanity have successfully completed the commercial-scale process validation of PFH-VAP. The product, a stable formulation of Vitamin A Palmitate intended for large-scale food fortification, is proposed to be marketed internationally under the brand name 'VIT A+'. While this validates the manufacturing feasibility at scale, financial details, expected revenue, and capex were not disclosed in the filing. In the recent quarter ending June 2026, Hexagon reported revenue of Rs 104.31 crore and net profit of Rs 8.07 crore.
- Completed commercial-scale process validation of PFH-VAP with partner Particles for Humanity on September 29, 2026
- Product is a stable formulation of Vitamin A Palmitate intended for large-scale food fortification
- Proposed to be marketed commercially under the brand name 'VIT A+' in international markets
- Hexagon reported Q1 Jun 2026 revenue of Rs 104.306 crore and net profit of Rs 8.073 crore
Hexagon Nutrition Limited announced that its Chairman & Executive Director, Arun Purushottam Kelkar, has completed his tenure and stepped down effective September 28, 2026, at the close of office hours. Kelkar has led the company since its incorporation. The company reported revenue of Rs 104.31 crore and net profit of Rs 8.07 crore in the June 2026 quarter. Investors should monitor subsequent filings regarding leadership succession and board reconstitution.
- Cessation of Arun Purushottam Kelkar as Chairman & Executive Director effective September 28, 2026
- Change occurred due to the completion of his scheduled term
- Company posted revenue of Rs 104.306 crore and net profit of Rs 8.073 crore in Q1 FY27 (Jun 2026)
Hexagon Nutrition Limited reported an update regarding voting outcomes on certain shareholder resolutions, disclosing that Promoter shareholders had abstained from voting. The company is actively seeking an independent legal opinion to decide on the appropriate course of action under applicable law. Further details on the specific resolutions or financial implications were not disclosed in the filing. Investors should note this development follows the company's June 2026 quarterly net profit of Rs 8.073 cr on revenue of Rs 104.306 cr.
- Promoter shareholders abstained from voting on certain resolutions as of September 23, 2026
- Company is currently seeking an independent legal opinion to determine next steps
- Hexagon Nutrition reported June 2026 quarterly revenue of Rs 104.306 cr and net profit of Rs 8.073 cr
- Specific resolution details and voting percentage breakdowns were not disclosed
At Hexagon Nutrition's 33rd Annual General Meeting held on September 22, 2026, public shareholders pushed back on executive compensation and leadership continuity. Three special resolutions failed to pass: Resolution 7 (remuneration of Chairman Arun Kelkar), Resolution 8 (remuneration of MD Vikram Kelkar), and Resolution 11 (re-appointment of Arun Kelkar as Chairman & Executive Director), all receiving 60.86% votes against from voting members. However, routine items including adoption of FY26 financial statements, dividend declaration, and revision of Joint MD Dr. Nikhil Kelkar's remuneration were approved.
- Resolution 7 (remuneration of Chairman Arun Kelkar) rejected with 60.86% votes cast against (2,468,131 votes against vs 1,587,029 in favour)
- Resolution 8 (remuneration of MD Vikram Kelkar) rejected with 60.86% votes cast against (2,468,131 votes against vs 1,587,009 in favour)
- Resolution 11 (re-appointment of Arun Kelkar as Chairman & Executive Director) defeated with 60.86% votes against
- Resolution 9 (remuneration revision for Joint MD Dr. Nikhil Kelkar) passed with near-unanimous approval (4,054,824 votes in favour)
- Resolution 3 approving dividend declaration for FY 2025-26 passed with 100% of votes polled in favour
Hexagon Nutrition Limited disclosed under SEBI SAST Regulations that promoter and Managing Director Vikram Arun Kelkar purchased 10,000 equity shares via open market transactions on September 17, 2026. Following this minor acquisition, his personal shareholding marginally increased from 21.12% (2,59,61,344 shares) to 21.13% (2,59,71,344 shares). The total paid-up share capital remains unchanged at 12,29,18,109 shares. At current market prices of Rs 66.3, the acquired stake represents a nominal transaction value of roughly Rs 6.6 lakh.
- Promoter Vikram Arun Kelkar acquired 10,000 equity shares via the open market on September 17, 2026
- Acquisition represents 0.0081% of the company's total voting capital
- Total holding of the acquirer increased from 21.12% (2,59,61,344 shares) to 21.13% (2,59,71,344 shares)
- Total voting capital of Hexagon Nutrition stands at 12,29,18,109 equity shares
Hexagon Nutrition Limited has dispatched physical letters containing the web-link for its FY2025-26 Annual Report and AGM Notice to members whose email addresses are not registered. The company's 33rd Annual General Meeting is scheduled to be held on September 22, 2026, at 11:30 AM IST via Video Conference. This filing is a statutory compliance disclosure under Regulation 36(1)(b) of SEBI Listing Regulations.
- 33rd Annual General Meeting scheduled for September 22, 2026 at 11:30 AM IST via VC/OAVM
- Intimation pursuant to Regulation 36(1)(b) of SEBI LODR Regulations
- Web-link sent to shareholders without registered email addresses for accessing the FY2025-26 Annual Report
Hexagon Nutrition Limited received an Order-in-Original from the Commissioner of Customs, Chennai - III, raising a total demand and penalty of ₹1,04,71,989 plus applicable interest. The demand pertains to its amalgamated subsidiary, Hexagon Nutrition Exports Private Limited, regarding alleged misclassification of CTH codes for DTA unit sales. The total demand of ₹1.05 cr represents approximately 13% of the company's Jun 2026 quarterly net profit of ₹8.07 cr. Hexagon stated it strongly disagrees with the findings and is preparing to file an appeal before the appellate authority.
- Total customs demand, fine, and penalty amount to ₹1,04,71,989 plus applicable interest
- Breakdown includes ₹81,71,989 in Customs Duty, ₹15,00,000 in fine, and ₹8,00,000 in penalty
- Order received on 29 August 2026 alleging CTH code misclassification for sales to DTA units
- Pertains to erstwhile subsidiary Hexagon Nutrition Exports, amalgamated via NCLT order dated 14 January 2026
Hexagon Nutrition Limited has issued the notice for its 33rd Annual General Meeting scheduled for September 22, 2026, along with its FY 2025-26 Annual Report. For FY26, the company reported revenue from operations of ₹3,826 million (up 18% YoY), EBITDA of ₹529 million (up 32% YoY), and Profit After Tax of ₹379 million (up 56% YoY). The report also highlights its public market debut following an IPO of ₹138.87 crore listed on June 12, 2026.
- 33rd AGM scheduled for Tuesday, September 22, 2026, via Video Conferencing.
- FY26 Revenue from operations reached ₹3,826 million, growing 18% YoY.
- FY26 EBITDA rose 32% YoY to ₹529 million, and PAT jumped 56% YoY to ₹379 million.
- Recapped listing on NSE and BSE on June 12, 2026, post a ₹138.87 crore IPO issue.
Hexagon Nutrition Limited disclosed that Dr. Nikhil Kelkar, Promoter and Joint Managing Director, acquired 16,400 equity shares (0.01% of total share capital) via open market purchases on 17th August 2026. Following this transaction, his individual shareholding increased from 2,12,16,068 shares (17.26%) to 2,12,32,468 shares (17.27%). The total equity share capital of the company stands at 12,29,18,109 shares.
- Acquisition of 16,400 equity shares representing 0.01% stake via open market transactions on 17th August 2026
- Pre-acquisition shareholding stood at 2,12,16,068 shares (17.26%)
- Post-acquisition shareholding increased to 2,12,32,468 shares (17.27%)
- Total paid-up and diluted equity capital stands at 12,29,18,109 shares
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.